Molecular Partners
Develops designed ankyrin repeat protein platform therapies used in ophthalmology, oncology, inflammation, and other therapeutic treatments.
Market cap
$138m
Enterprise value
($2m)
Share price
$3.75 MOLN
Company register number
CH-020.3.028.228-2
Authorizing premium user...